Zenith Capital Corporation Share Price
Equities
ZENI.P
CA98936P1071
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.105 CAD | 0.00% | 0.00% | 0.00% |
Sales 2022 | - | Sales 2023 | - | Capitalization | 443K 605K 35.25M |
---|---|---|---|---|---|
Net income 2022 | - 0 0 | Net income 2023 | - 0 0 | EV / Sales 2022 | - |
Net cash position 2022 | 72.43K 98.97K 5.77M | Net cash position 2023 | 79.53K 109K 6.33M | EV / Sales 2023 | - |
P/E ratio 2022 |
-2.45
x | P/E ratio 2023 |
-2.33
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.89% |
Managers | Title | Age | Since |
---|---|---|---|
Harry Katevatis
CEO | Chief Executive Officer | 82 | 10/03/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Katevatis
CEO | Chief Executive Officer | 82 | 10/03/19 |
Vivian Katsuris
BRD | Director/Board Member | 59 | 14/03/19 |
Director/Board Member | 62 | 14/03/19 |
1st Jan change | Capi. | |
---|---|---|
0.00% | 323K | |
+1.61% | 42.75B | |
+47.70% | 41.61B | |
+12.07% | 41.34B | |
-8.83% | 26.59B | |
+6.89% | 25.49B | |
-23.36% | 18.12B | |
+30.01% | 12.24B | |
-2.42% | 11.76B | |
+8.06% | 11B |
- Stock Market
- Equities
- ZENI.P Stock